This webinar will provide participants with an understanding of the regulatory reporting requirements when Adverse Drug Reaction (i.e. Adverse Events) occurs at the investigational stage of a Clinical Trial.
Adverse event identification and reporting requirements will be reviewed, as well as FDA training and ICH roles in the drug safety process. The webinar will also discuss ICH training guidelines and current regulatory issues regarding adverse event reporting requirements specific to the United States.
Why Should You Attend:
• Understand what Adverse Events, Serious Adverse Events
• Learn the responsibilities of the Sponsor, Site/Clinical Investigator and Regulatory Agency in the reporting of Adverse Events
• Become familiar with current issues regarding Adverse Event reporting specific to the United States
• Have an understanding of what role the FDA and ICH Guidelines play in determining the safety of a drug
Course Objectives:
• Identify when a Serious Adverse Event does not require reporting
• Understand what the site obligations are in both assessing causality of adverse events as well as reporting these events to the sponsor
• Learn the circumstances under which Investigator Notification Letters are released as well as responsibilities for notification of clinical sites as well as the FDA
Course Outline:
• Adverse Event (AE) and Serious Adverse Event Terminology: Definitions
• Roles & Responsibilities of the Sponsor and the Regulatory Agency in AE reporting
• Exclusions from SAE Reporting
• Causality Assessments
• Site Obligations
• Investigator Notification Letters/ IND Safety Reports
• Case Studies and Scenarios
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Clinical Research Professionals
• Safety Surveillance Personnel
• Regulatory Affairs Personnel
• Medical Affairs Personnel
• QA/QC Managers
Protocol Deviations: Documenting, Managing, and Reporting
Get Instant Access 60 Minutes View Program |
The Sunshine Act: Reporting for Clinical Trials
Get Instant Access 60 Minutes View Program |
Analyzing Assay Validation for Clinical Diagnostics
Get Instant Access 60 Minutes View Program |
The Secret of Study Conduct Documentation to ensure a successful Audit: What the FDA Inspectors looks for
Get Instant Access 90 Minutes View Program |
General Data Protection Regulation (GDPR): Compliance for Clinical Trials
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry